Alessandra Nicoletti

Alessandra Nicoletti publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Alessandra Nicoletti sits on this spectrum.

Alessandra Nicoletti D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Alessandra Nicoletti sits on this spectrum.

Best Publications

• The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease

  Paolo Barone;Angelo Antonini;Carlo Colosimo;Roberto Marconi

  1788
  Citations

• International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.

  P. Martinez-Martin;C. Rodriguez-Blazquez;K. Abe;K. B. Bhattacharyya;K. B. Bhattacharyya

  312
  Citations

• The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life.

  Angelo Antonini;Paolo Barone;Roberto Marconi;Letterio Morgante

  289
  Citations

• The relevance of gender in Parkinson’s disease: a review

  Marina Picillo;Alessandra Nicoletti;Vincenza Fetoni;Barbara Garavaglia

  273
  Citations

• Metals and neurodegenerative diseases. A systematic review.

  Calogero Edoardo Cicero;Giovanni Mostile;Rosario Vasta;Venerando Rapisarda

  266
  Citations

• Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy

  Annamaria Vallelunga;Marco Ragusa;Stefania Di Mauro;Tommaso Iannitti

  197
  Citations

• Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study.

  Carlo Colosimo;Letterio Morgante;Angelo Antonini;Paolo Barone

  193
  Citations

• Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis.

  Elisa Bruno;Alessandro Bartoloni;Lorenzo Zammarchi;Marianne Strohmeyer

  171
  Citations

• Prevalence of epilepsy in rural Bolivia A door-to-door survey

  A. Nicoletti;A. Reggio;A. Bartoloni;G. Failla

  158
  Citations

• Toxoplasmosis and epilepsy--systematic review and meta analysis.

  Graziella Quattrocchi;Alessandra Nicoletti;Benoit Marin;Elisa Bruno

  156
  Citations

• Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale

  Angelo Antonini;Giovanni Abbruzzese;Luigi Ferini-Strambi;Barbara Tilley

  155
  Citations

• Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.

  Cristina Barbagallo;Giovanni Mostile;Gloriangela Baglieri;Flavia Giunta

  155
  Citations

• Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis

  F. Nicoletti;F. Nicoletti;F. Patti;C. Cocuzza;P. Zaccone

  153
  Citations

• Basal ganglia calcifications (Fahr’s syndrome): related conditions and clinical features

  Giulia Donzuso;Giovanni Mostile;Alessandra Nicoletti;Mario Zappia

  142
  Citations

• Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study.

  Unknown

  137
  Citations

• Epilepsy, cysticercosis, and toxocariasis: A population-based case-control study in rural Bolivia

  A. Nicoletti;A. Bartoloni;A. Reggio;F. Bartalesi

  134
  Citations

• Increased serum levels of interleukin-18 in patients with multiple sclerosis.

  Ferdinando Nicoletti;R Di Marco;Katia Domenica Mangano;Francesco Patti

  132
  Citations

• Neurofunctional correlates of attention rehabilitation in Parkinson’s disease: an explorative study

  Antonio Cerasa;Maria Cecilia Gioia;Maria Salsone;Giulia Donzuso

  124
  Citations

• Mild cognitive impairment in Parkinson’s disease: the Parkinson’s disease cognitive study (PACOS)

  Roberto Monastero;Calogero Edoardo Cicero;Roberta Baschi;Marco Davì

  123
  Citations

• Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b).

  F. Nicoletti;R. Di Marco;F. Patti;E. Reggio

  116
  Citations

• Meta-analysis of the association between cysticercosis and epilepsy in Africa.

  Fabrice Quet;Maëlenn Guerchet;Sebastien D. S. Pion;Sebastien D. S. Pion;Edgard Brice Ngoungou

  112
  Citations

• Natural history and mortality of chronic epilepsy in an untreated population of rural Bolivia: A follow-up after 10 years

  Alessandra Nicoletti;Vito Sofia;Giuseppina Vitale;Sara Irene Bonelli

  110
  Citations

• CIRCULATING SERUM LEVELS OF IL-1ra IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS ARE NORMAL DURING REMISSION PHASES BUT SIGNIFICANTLY INCREASED EITHER DURING EXACERBATIONS OR IN RESPONSE TO IFN-β TREATMENT

  Ferdinando Nicoletti;Francesco Patti;Roberto Di Marco;Paola Zaccone

  110
  Citations